denialsolve.com
DenialSolve
Turn Denials Into Revenue
.com checking...
Find your own domain
Opportunity
Contract compliance analysts at mid-sized hospitals lose millions annually because they cannot quickly determine if a denial violates payer contract terms buried in unstructured PDFs and scanned documents. With LLMs now achieving over 90% accuracy on legal document parsing, DenialSolve automatically extracts key clauses from any contract and analyzes each denial for violations, flagging recoverable underpayments. By generating ready-to-submit appeal packets and charging only on recovered revenue, DenialSolve delivers a 15–30% recovery of previously written-off denial revenue while cutting manual review time by 90%. The result: a clear economic payoff that turns a costly pain point into a new revenue stream.
Prefer to build this yourself?
A solo developer Micro-SaaS concept also exists for this domain — scoped for one person to build and grow to $5k MRR.
View Solo Dev Idea →Improve this idea with AI
Research competitors and sharpen the wedge
Open this proposal in another AI with a research prompt: it will find competitors with real traction and recurring complaints, then help you improve the idea with a sharper wedge and MVP focused on fixing what incumbents get wrong.
Build this idea with Claude Code or Codex. Both links open with a coding-agent prompt for the first MVP.
Interested in denialsolve.com?
Register this domain
Check availability and register at your preferred registrar.
Start with the buyer and the pain. The rest of the idea only matters if this audience has a reason to pay now.
Who Pays
Revenue Cycle Contract Compliance Analysts at U.S. acute-care hospitals with 200+ beds
Painful Problem
Contract compliance analysts cannot quickly determine if a denial violates payer contract terms because contracts are stored as unstructured PDFs and scanned documents, causing the hospital to write off millions annually in unrecovered underpayments.
Why Now
LLMs (GPT-4, Claude 3) have crossed a threshold in legal document parsing accuracy (90%+ on clause extraction) making automated contract analysis practical. Combined with hospital margin pressure post-COVID (average 3% margin), the ROI case for automated denial recovery is compelling. This was impossible 2 years ago.
Audience Alternatives
- Hospital Revenue Cycle Departments Implementing a solution that streamlines the denial management process, reducing administrative costs and improving cash flow.
- Medical Billing Companies Offering a solution that integrates with existing billing systems to automate denial management, reducing manual workload and improving efficiency.
- Large Physician Groups (100+ providers) Implementing a solution that provides real-time analytics and reporting to identify and address denial trends promptly.
- Dental Practices (Dentists) Offering a cost-effective solution tailored to the specific needs of dental practices to manage claim denials efficiently.
- Ambulatory Surgery Centers (ASCs) Implementing a solution that integrates with existing ASC management systems to automate denial management, reducing manual workload and improving efficiency.
Hospitals face massive denial volumes with high revenue impact, have dedicated budget owners (VP of Revenue Cycle), and this domain directly addresses their core problem. The market is large, pain is acute, and willingness to pay is high.
Audience Research
Hospitals are experiencing significant revenue losses due to claim denials, with some reports indicating losses of over $48 billion annually. ([techtarget.com](https://www.techtarget.com/revcyclemanagement/news/366641065/Hospitals-lost-over-48B-from-claims-denials-uncollected-bills?utm_source=openai)) The administrative cost of fighting denials reached $25.7 billion in 2023. ([gomedicalbilling.com](https://www.gomedicalbilling.com/medical-billing-denial-statistics-2026?utm_source=openai)) The initial claim denial rate increased by 2.4% in 2024 to a rate of 11.81% of claims. ([techtarget.com](https://www.techtarget.com/revcyclemanagement/news/366625109/Initial-claim-denial-rates-put-revenue-cycle-in-tough-spot?utm_source=openai)) Hospitals have dedicated budget owners, such as the VP of Revenue Cycle, who are responsible for managing these challenges.
- Hospital Revenue Cycle Departments Hospitals are losing significant revenue due to claim denials, with some reports indicating losses of over $48 billion annually. (techtarget.com) The administrative cost of fighting denials reached $25.7 billion in 2023. (gomedicalbilling.com) The initial claim denial rate increased by 2.4% in 2024 to a rate of 11.81% of claims. (techtarget.com) Hospitals have dedicated budget owners, such as the VP of Revenue Cycle, who are responsible for managing these challenges.
- Medical Billing Companies Medical billing companies are facing increased denial rates, with 46% reporting higher rates compared to the previous year. (tebra.com) The administrative cost of fighting denials reached $25.7 billion in 2023. (gomedicalbilling.com) The global revenue cycle management market size was approximately $384.6 billion in 2025, projected to reach $894.3 billion by 2033. (tebra.com)
- Large Physician Groups (100+ providers) Large physician groups are experiencing denial rates of 10% or more, leading to significant revenue losses. (medicaleconomics.com) The administrative cost of fighting denials reached $25.7 billion in 2023. (gomedicalbilling.com)
- Dental Practices (Dentists) Dental practices are facing denial rates of 10% or more, leading to revenue losses. (medicaleconomics.com) The administrative cost of fighting denials reached $25.7 billion in 2023. (gomedicalbilling.com)
- Ambulatory Surgery Centers (ASCs) ASCs are experiencing denial rates of 10% or more, leading to significant revenue losses. (medicaleconomics.com) The administrative cost of fighting denials reached $25.7 billion in 2023. (gomedicalbilling.com)
Then test whether the product is a credible answer to that pain, and whether this domain gives the idea a memorable strategic shape.
What It Does
DenialSolve is an AI-powered platform that ingests unstructured payer contracts (PDFs, scanned docs), extracts key clauses (reimbursement, medical necessity, timely filing), and automatically analyzes each denial against those clauses. It flags violations, estimates recovery potential, and generates ready-to-submit appeal packets. Analysts review and approve via a real-time collaboration workspace, then submit through payer portals or direct APIs.
How It Creates Value
Recover 15–30% of previously written-off denial revenue by automatically identifying contractually valid appeals, reducing manual contract review time by 90%, and eliminating missed appeal deadlines.
Proof In The Product
- Auto-analyze: Upload a denial file and see which denials violate contract terms, with evidence highlighted.
- Appeal builder: One-click generation of a complete appeal packet with cited contract clauses and supporting documentation.
- Deadline tracker: Automated alerts for timely filing limits, preventing missed appeal windows.
- Recovery dashboard: Real-time view of recovered revenue, denial trends, and payer compliance patterns.
Why This Domain Fits
DenialSolve.com directly communicates the core outcome: solving denial problems. It’s memorable, action-oriented, and immediately signals value to revenue cycle buyers searching for denial solutions.
First Customer Profile
VP of Revenue Cycle at a 300-bed community hospital with $500M annual revenue, 18% denial rate, and a team of 3 analysts manually checking contracts. Triggered by a recent audit showing $2M in unrecovered underpayments. Budget from revenue recovery funds.
A fundable idea also needs a path to revenue, distribution, and defensibility.
Economic Engine
Outcome-based pricing: 20% of recovered revenue from successfully appealed denials identified by the platform. No upfront license fees. Alternatively, a flat per-claim fee ($5–$15) for high-volume hospitals. High margins as AI handles the heavy lifting.
Why It Wins
Unlike generic RCM denial management tools (which only track status) or legal AI (which is too broad), DenialSolve is purpose-built for hospital contract compliance, uses an LLM fine-tuned on medical payer contract language, and charges only on recovered revenue—aligning our incentives with the hospital's.
Pricing Assumptions
Pilot: 20% of recovered denials, capped at $50K. Full ACV: $100K–$300K per hospital (based on denial volume). Gross margin: 70%+ (AI compute + small human QA team). Expansion: multiple payers, then clinical denial workflows.
Market Size
U.S. hospitals lose ~$38 billion annually to denials, of which an estimated 10–15% are recoverable through contract compliance (bottom-up: 5,000 hospitals × $8M average lost per hospital × 12% recovery = $4.8B addressable). The broader RCM software market is $15.5B and growing at 7.5% CAGR. (Source: Emergen Research 2024)
Market Wedge
First target: mid-sized hospitals (200–500 beds) with 15–20% denial rates but no dedicated contract compliance team. They already budget for denial write-offs and are easier to reach than large academic systems. Use a single-payer (e.g., Medicare Advantage) contract to prove ROI in 90 days.
Buyer & Sales Motion
Economic buyer: VP of Revenue Cycle. Champion: Director of Denial Management or Contract Compliance. Procurement hurdles: IT security review (data residency, HIPAA), legal review of outcome-based pricing. Pilot: 3-month paid pilot with one payer contract (e.g., Blue Cross). Sales cycle: 3–6 months.
Competition
Direct: Denial management platforms (Waystar, Experian Health) focus on tracking, not contract analysis. RPA vendors (UiPath) require manual setup. Legal AI (Kira, LexisNexis) targets law firms, not hospitals. DenialSolve wins via specialization and outcome pricing.
Distribution
1) Direct sales via hospital RCM conferences (HFMA, Becker’s). 2) EHR partnerships (Epic App Orchard, Cerner) for embedded integration. 3) White-label for RCM outsourcing firms. Initially, outbound to mid-market hospitals using denial rate data from public charity reports.
Moat
Proprietary fine-tuned LLM on 10,000+ payer contracts with clause-level annotations (hard to replicate). Workflow integration depth: connects to EHR, payer portals, and appeals systems—3+ integrations create switching costs. As more hospitals use the platform, we accumulate denial-to-outcome data to improve recovery algorithms, a form of network effect.
90-Day MVP
In 90 days: Build a demo that ingests one payer contract (PDF), extracts 20 key clauses, and analyzes a sample of 100 denials. Human analysts validate and submit appeals manually. Track recovery rate vs. baseline. No API or portal integration initially—manual data upload.
Finally, the diligence layer shows what still needs to be proven before this becomes more than a promising concept.
Validation Plan
- 1. Conduct 10–15 discovery interviews with VP of Revenue Cycle at mid-sized hospitals; ask about current contract review process, denial write-off amounts, and willingness to pilot outcome-based pricing.
- 2. Search Indeed/LinkedIn for 'contract compliance analyst' and 'denial specialist' roles; record job posting count and median salary (proxy for manual effort and market size).
- 3. Create a landing page (denialsolve.com) with a 'Pilot Waitlist' CTA; drive targeted LinkedIn ads and measure conversion rate.
- 4. Identify 3 hospitals currently using external denial recovery agencies; propose a pilot where DenialSolve replaces the agency for a specific payer contract.
Key Risks
- LLM accuracy on nuanced contract clauses (e.g., so-called 'gag clauses') could miss valid denials. Mitigation: human-in-the-loop review during pilot; build confidence thresholds and escalate ambiguous cases.
- Hospitals may be reluctant to share payer contract data due to legal restrictions. Mitigation: sign NDAs and use HIPAA-compliant infrastructure; start with publicly available Medicare contracts.
- Integration with existing EHR/RCM systems (Epic, Cerner) may take 6+ months. Mitigation: MVP uses CSV/PDF upload; later develop certified integrations once pilot proves value.
Fundability Verdict
Venture-scale if we can prove 15%+ recovery rates and secure 3 paid pilots within 6 months. Hardest assumption: hospitals will trust an AI platform with contract analysis. Pilot results and LLM accuracy benchmarks (e.g., 95% recall on clause extraction) are critical de-risking milestones.
Quality Review
63/100
The concept is well-defined with a clear problem, solution, and outcome-based pricing. However, it lacks strong market evidence, has moderate defensibility (reliant on unproven proprietary LLM), and distribution is generic. The evidence base is thin, critical for investor confidence.
Regenerated after critique: 2 attempts.
- Urgency
- 8/10
- Domain Fit
- 8/10
- Market Size
- 7/10
- Specificity
- 9/10
- Distribution
- 5/10
- Market Wedge
- 7/10
- Defensibility
- 5/10
- Evidence Quality
- 3/10
- Frontier Alignment
- 8/10
- Willingness To Pay
- 8/10
Quality Strengths
- Clear, measurable ROI (recovered revenue) aligned with outcome-based pricing.
- Specific buyer persona and first customer profile with realistic budget trigger.
- Well-defined problem statement that describes hospital's painful current state.
- Why-now tied to LLM capability inflection (90%+ parsing accuracy) and hospital margin pressure.
Quality Weaknesses
- Very thin market evidence: only one source for TAM, no interview or job posting data.
- Moat based on 'proprietary fine-tuned LLM' but no specifics on data acquisition or model training.
- Distribution strategy relies on generic channels (conferences, EHR partnerships) without established relationships.
- Long sales cycle (3-6 months) and potential reluctance to share contract data are unaddressed risks.
Missing Evidence
- Job posting data for contract compliance analysts and denial specialists (to quantify manual effort and market size).
- Results from 10-15 discovery interviews with target buyers (VP of Revenue Cycle).
- Verified revenue signals from competitors (e.g., Waystar, Experian Health) to validate willingness to pay.
- Specific examples of hospitals with current denial write-off amounts and existing denial management processes.
Pros
- Clear, measurable ROI (recovered revenue) makes it easy to sell to CFOs.
- Outcome-based pricing reduces upfront barriers and aligns incentives.
- Large TAM with high willingness to pay (hospitals already budget for denial write-offs).
- Strong moat via proprietary contract dataset and workflow integration.
Cons
- Long sales cycle (3–6 months) slows initial traction.
- Dependence on LLM accuracy for nuanced clauses is a technical risk.
- Hospitals may resist sharing payer contracts due to confidentiality.
- Need to integrate with multiple EHR/RCM systems increases development cost.